IRIS Accounts Production v24.1.0.578 10287685 Board of Directors 1.8.22 31.7.23 31.7.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102876852022-07-31102876852023-07-31102876852022-08-012023-07-31102876852021-07-31102876852021-08-012022-07-31102876852022-07-3110287685ns15:EnglandWales2022-08-012023-07-3110287685ns14:PoundSterling2022-08-012023-07-3110287685ns10:Director12022-08-012023-07-3110287685ns10:PrivateLimitedCompanyLtd2022-08-012023-07-3110287685ns10:SmallEntities2022-08-012023-07-3110287685ns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3110287685ns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3110287685ns10:SmallCompaniesRegimeForAccounts2022-08-012023-07-3110287685ns10:FullAccounts2022-08-012023-07-311028768512022-08-012023-07-3110287685ns5:CurrentFinancialInstruments2023-07-3110287685ns5:CurrentFinancialInstruments2022-07-3110287685ns5:Non-currentFinancialInstruments2023-07-3110287685ns5:Non-currentFinancialInstruments2022-07-3110287685ns5:ShareCapital2023-07-3110287685ns5:ShareCapital2022-07-3110287685ns5:RetainedEarningsAccumulatedLosses2023-07-3110287685ns5:RetainedEarningsAccumulatedLosses2022-07-3110287685ns10:RegisteredOffice2022-08-012023-07-3110287685ns5:NetGoodwill2022-08-012023-07-3110287685ns5:NetGoodwill2023-07-3110287685ns5:PlantMachinery2022-07-3110287685ns5:PlantMachinery2022-08-012023-07-3110287685ns5:PlantMachinery2023-07-3110287685ns5:PlantMachinery2022-07-3110287685ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-3110287685ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-07-3110287685ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2023-07-3110287685ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2022-07-31
REGISTERED NUMBER: 10287685 (England and Wales)















ABRA HEALTHCARE LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2023






ABRA HEALTHCARE LTD (REGISTERED NUMBER: 10287685)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023










Page

Statement of Financial Position 1

Notes to the Financial Statements 3


ABRA HEALTHCARE LTD (REGISTERED NUMBER: 10287685)

STATEMENT OF FINANCIAL POSITION
31 JULY 2023

2023 2022
Notes £    £   
Fixed assets
Intangible assets 4 357,930 -
Tangible assets 5 9,280 12,373
367,210 12,373

Current assets
Stocks 51,150 37,000
Debtors 6 505,768 139,881
Cash at bank and in hand 161,039 207,005
717,957 383,886
Creditors
Amounts falling due within one year 7 (1,006,584 ) (362,303 )
Net current (liabilities)/assets (288,627 ) 21,583
Total assets less current liabilities 78,583 33,956

Creditors
Amounts falling due after more than one
year

8

-

(20,631

)

Provisions for liabilities (2,320 ) (2,351 )
Net assets 76,263 10,974

Capital and reserves
Called up share capital 100 100
Retained earnings 76,163 10,874
76,263 10,974

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ABRA HEALTHCARE LTD (REGISTERED NUMBER: 10287685)

STATEMENT OF FINANCIAL POSITION - continued
31 JULY 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 July 2024 and were signed on its behalf by:





Haval Karim Aziz - Director


ABRA HEALTHCARE LTD (REGISTERED NUMBER: 10287685)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023


1. Statutory information

Abra Healthcare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10287685

Registered office: Wellcare Pharmacy
Malvern Way
Hastings
TN34 3PX

The presentation currency of the financial statements is the Pound Sterling (£).


2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill is measured at cost less accumulated amortisation and accumulated impairment loss. It is amortised on a straight line basis over its useful life. Where a reliable estimate of the useful life cannot be determined, the life is presumed to be 10 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated
useful life.

Plant and machinery: 25% on reducing balance.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

ABRA HEALTHCARE LTD (REGISTERED NUMBER: 10287685)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023


2. Accounting policies - continued

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Directors' loans (being repayable on demand), trade debtors and trade creditors are measured at the undiscounted amount of the cash or other consideration expected to be paid or received.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

ABRA HEALTHCARE LTD (REGISTERED NUMBER: 10287685)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023


2. Accounting policies - continued

Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

3. Employees and directors

The average number of employees during the year was 11 (2022 - 6 ) .

4. Intangible fixed assets
Goodwill
£   
Cost
Additions 397,700
At 31 July 2023 397,700
Amortisation
Amortisation for year 39,770
At 31 July 2023 39,770
Net book value
At 31 July 2023 357,930

5. Tangible fixed assets
Plant and
machinery
£   
Cost
At 1 August 2022
and 31 July 2023 51,011
Depreciation
At 1 August 2022 38,638
Charge for year 3,093
At 31 July 2023 41,731
Net book value
At 31 July 2023 9,280
At 31 July 2022 12,373

ABRA HEALTHCARE LTD (REGISTERED NUMBER: 10287685)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023


6. Debtors
2023 2022
£    £   
Amounts falling due within one year:
Trade debtors 413,377 87,401
Other debtors 92,391 11,752
505,768 99,153

Amounts falling due after more than one year:
Other debtors - 40,728

Aggregate amounts 505,768 139,881

7. Creditors: amounts falling due within one year
2023 2022
£    £   
Trade creditors 458,525 316,617
Taxation and social security 74,983 34,728
Other creditors 473,076 10,958
1,006,584 362,303

8. Creditors: amounts falling due after more than one year
2023 2022
£    £   
Other creditors - 20,631

9. Related party disclosures

At 31 July 2023 the company owed the directors £43,583 (2022: company owed directors £20,096 Dr). No interest has been charged in respect of this loan and it is classified in creditors due within one year.